Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
4
Neutral
2
Bullish
8
Bearish
36
Neutral
2
Bullish
8
Bearish
32
Neutral
0
Bullish
0
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q4 FY26
Investor Presentation
Q2 FY26
Gem Aromatics Ltd (GEMAROMA) is currently trading at 135.05 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Gem Aromatics Limited manufactures essential oils, aroma chemicals and value‑added derivatives, operating processing and manufacturing plants including Silvassa, Budaun and the recently commissioned Dahej Krystal facility, serving domestic and export customers with a product portfolio spanning mint, clove, cooling agents and specialty aroma chemistries. Q1 FY27 delivered year‑on‑year consolidated revenue growth to INR99 crores despite a seasonally soft quarter; consolidated EBITDA was INR3.3 crores (3.3% margin) and the consolidated loss of INR7.9 crores reflected higher depreciation after capitalizing Dahej and adverse product mix because of Madagascar clove supply disruption. The Dahej Krystal facility is the strategic growth engine: ~INR270 crore capex with ~INR265 crores capitalized, commercial production for Safranal and multiple Gemcool cooling agents commenced, trial production for phenol derivatives is scheduled and management expects scale‑up and recurring supplies to drive revenue from Q3 FY27 and more meaningfully into FY28. Management is explicitly pivoting away from a mint‑centric portfolio toward non‑mint and higher‑value specialty molecules supported by a strong R&D pipeline and a multipurpose manufacturing platform designed to enable product customization, faster customer qualification and margin improvement over the medium term. The company has approved a Brazil subsidiary to expand distribution and presence in Latin America, signaling deliberate international expansion to support exports and create a dedicated platform for essential oils, aromatic chemicals and specialty products in that geography.
Over the past 52 weeks, Gem Aromatics Ltd has traded between a low of ₹131.00 and a high of ₹237.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Gem Aromatics Ltd has a market capitalization of approximately 702.07. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Gem Aromatics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -48.65 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 702.07 Cr, Gem Aromatics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Gem Aromatics Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Gem Aromatics Ltd is -48.65. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Chemicals & Petrochemicals
Specialty Chemicals
705 Cr
Moderate Risk
-48.9
35.0
—
1.6
237.00
131.00
Sales CAGR
Profit CAGR
ROE
ROCE
